Evaxion A/S American Depositary Share (EVAX)

🚫 Evaxion A/S American Depositary Share does not pay dividends

Company News

Untreated Metastatic or Unresectable Melanoma Clinical Trial Pipeline Expands as 10+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight
GlobeNewswire Inc. • Delveinsight • August 26, 2025

The market for untreated metastatic melanoma is poised for strong growth, with over 10 companies driving innovation through advanced immunotherapies, targeted treatments, and combination therapies.

Biotech Underdogs Line Up for Pivotal Shots at Game-Changing Cancer Treatments
Benzinga • Prnewswire • July 29, 2025

Several biotech companies are developing innovative cancer treatments, with promising clinical trial results in various cancer types, focusing on immunotherapy and personalized medicine approaches.

Here's Why Evaxion Biotecch (EVAX) Is a Great 'Buy the Bottom' Stock Now
Zacks Investment Research • Zacks Equity Research • June 13, 2024

Evaxion Biotecch (EVAX) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Best Penny Stocks To Buy: 3 High Volume Stocks To Watch Today
PennyStocks • J. Phillip • September 23, 2022

High volume penny stocks to watch before next week. The post Best Penny Stocks To Buy: 3 High Volume Stocks To Watch Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Stocks To Watch: Jobs Report And Earnings To Dominate Big Week
Seeking Alpha • SA Stocks To Watch • July 31, 2021

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week